Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals
- 1 December 2017
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 36, 74-78
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1Computational and Structural Biotechnology Journal, 2012
- Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian CancerMayo Clinic Proceedings, 2010
- PARP inhibition in BRCA-mutated breast and ovarian cancersThe Lancet, 2010
- PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancerF1000 Biology Reports, 2010
- Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic AnalysisAnnals of Human Genetics, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerHuman Mutation, 2001
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995